Sweden sends forth ambassadors to ensure lifesciences schnapps back into shape
This article was originally published in Scrip
Sweden used to be a major player in the life sciences industry. The pacemaker, the Gamma knife and the anaesthetic xylocaine were all developed in Sweden. But in recent years there have been fewer high-profile innovative products coming out of the country. Scrip went to Stockholm for the launch of the Stockholm-Uppsala ambassador programme and to investigate the uniting of the country's two largest life science clusters and their chances of success.